Hubei Xiangyuan New Material Technology Inc. Stocks

CN¥ 33.32Last Updated 29.04.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

CN¥ 644.73M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 33.32
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hubei Xiangyuan New Material Technology Inc. engages in the research, development, production, and sale of cross-linked polyolefin and silicone foams in China. It offers irradiation cross-linked polyethylene foam; radiation-cross-linked, semirigid, and closed-cell long sheet foam; chemical crosslinked polyethylene foam; 520 polyolefin foam; polyurethane foam; HFPP foam; silicone foam; and other products. The company's products are used in automotive interior, sports and leisure, packaging and cushioning, medical, air-conditioning, and other fields, as well as in construction materials, electronic materials, toys, pipe insulation and anti-condensation materials, miscellaneous industrial materials, consumer goods, and healthcare products. Hubei Xiangyuan New Material Technology Inc. was founded in 2003 and is headquartered in Hanchuan, China.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks